• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.95% Nasdaq Down2.40%

    diaDexus, Inc. (DDXS)

    -Other OTC
    0.34 Up 0.01(1.99%) Jun 29, 3:51PM EDT
    |Pre-Market : NaN
    Add to Portfolio
    ProfileGet Profile for:
    diaDexus, Inc.
    349 Oyster Point Boulevard
    South San Francisco, CA 94080
    United States - Map
    Phone: 650-246-6400
    Website: http://www.diadexus.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Medical Laboratories & Research
    Full Time Employees:41

    Business Summary 

    diaDexus, Inc., a life sciences company, focuses on the development and commercialization of cardiovascular diagnostic products addressing needs in cardiovascular disease. Its products include PLAC ELISA Test and the PLAC Activity Test that are designed to provide information on traditional risk factors, such as cholesterol levels to help identify individuals at risk of suffering a heart attack or stroke. The company’s PLAC ELISA Test is an aid in predicting risk for coronary heart disease (CHD) and ischemic strokes associated with atherosclerosis; and PLAC Test for Lp-PLA2 (lipoprotein-associated phospholipase A2) Activity is used in conjunction with clinical evaluation and patient risk assessment as an aid in predicting risk of CHD in patients with no prior history of cardiovascular events. Its pipeline of proprietary biomarkers comprises proADM, proET-1, and proANP for the treatment of heart failure diseases. The company markets its products to various national and regional clinical reference laboratories in the United States, Europe, and internationally. diaDexus, Inc. is headquartered in South San Francisco, California.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on diaDexus, Inc.

    Key Executives 
     PayExercised
    Dr. Lori F. Rafield Ph.D., 60
    Chairman, Chief Exec. Officer and Chairman of Nominating & Corp. Governance Committee
    540.00K0.00
    Dr. Emilia Zychlinsky Bulaevsky Ph.D., 59
    Chief Technology Officer and Exec. VP
    431.00K0.00
    Dr. Kenneth C. Fang M.D., 52
    Chief Medical Officer
    195.00K0.00
    Ms. Leone D. Patterson , 52
    Chief Financial Officer
    N/AN/A
    Mr. Christopher P. Lowe M.B.A., 47
    Chief Accounting Officer
    N/AN/A
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders